Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
Live vaccines against fowlpox virus, which causes moderate pathology in poultry and is the type species of the Avipoxvirus genus, were developed in the 1920s. Development of recombinant fowlpox virus vector vaccines began in the 1980s, for use not only in poultry, but also in mammals including human...
Principais autores: | Skinner, M, Laidlaw, S, Eldaghayes, I, Kaiser, P, Cottingham, MG |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2005
|
Registros relacionados
-
Efficacy of Fowlpox Virus Vector Vaccine Expressing VP2 and Chicken Interleukin-18 in the Protection against Infectious Bursal Disease Virus
por: Ibrahim Eldaghayes, et al.
Publicado em: (2023-11-01) -
Different levels of immunogenicity of two strains of Fowlpox virus as recombinant vaccine vectors eliciting T-cell responses in heterologous prime-boost vaccination strategies.
por: Cottingham, MG, et al.
Publicado em: (2006) -
Construction of Deletion-knockout Mutant Fowlpox Virus (FWPV)
por: Stephen Laidlaw, et al.
Publicado em: (2014-05-01) -
Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules
por: David B. Boyle, et al.
Publicado em: (2004-07-01) -
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.
por: Webster, D, et al.
Publicado em: (2006)